Riskpilot← Back to searchSign inGet full accessFasanvejens Dyreklinik ApS
APSActiveCVR 40619127Søndre Fasanvej 93Veterinary activities · NACE 7500Est. 201923 employeeswww.fasanvejensdyreklinik.dk
Revenue 2025
DKK 10,8M
-3% vs 2024
EBITDA margin
22.3%
+17% vs 2024
Equity ratio
79.8%
Financial strength
Net profit 2025
DKK 1,7M
+5% vs 2024
| Revenue | DKK 10,8M | -3% |
| EBITDA | DKK 2,4M | +17% |
| Net profit | DKK 1,7M | +5% |
| Total assets | DKK 9,2M | -30% |
| Equity | DKK 7,4M | -12% |
| Employees | 23 | — |
Legal name
Fasanvejens Dyreklinik ApS
CVR number
40619127
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
25. juni 2019
Share capital
DKK 50.000
Employees
23 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen i forening med et medlem af direktionen eller af den samlede bestyrelse.
Company purpose
Virksomhedens formål er drive virksomhed som dyreklinik.
Address
Søndre Fasanvej 93
Email
bibi.lindschouw@evidensia.dk
Website
www.fasanvejensdyreklinik.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6.143 | 7.311 | 9.488 | 11.146 | 10.829 |
| Staff expenses | -5.974 | -7.787 | -8.387 | -9.090 | -8.390 |
| EBITDA | 169 | -476 | 1.101 | 2.056 | 2.410 |
| Depreciation & amort. | -391 | -414 | -405 | -143 | -267 |
| EBIT | -221 | -889 | 696 | 1.913 | 2.143 |
| Net financials | -15 | 814 | 363 | 125 | 5 |
| Profit before tax | -236 | -75 | 1.060 | 2.038 | 2.148 |
| Tax | -51 | -12 | 232 | 449 | 474 |
| Net profit | -186 | -63 | 827 | 1.589 | 1.675 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9.215 | 10.471 | 11.769 | 13.163 | 9.246 |
| Equity | 6.074 | 7.242 | 7.569 | 8.375 | 7.375 |
| Long-term debt | 344 | 355 | 368 | 379 | 393 |
| Short-term debt | 1.552 | 1.294 | 2.010 | 2.591 | 1.388 |
| Total debt | 1.896 | 1.649 | 2.378 | 2.970 | 1.781 |
EBITDA margin
22.3%
This company
15.8%
Market median
+41% vs market
20212025
Equity ratio
79.8%
This company
38.2%
Market median
+109% vs market
20212025
Return on equity
22.7%
This company
18.4%
Market median
+23% vs market
20212025
Net profit margin
15.5%
This company
8.1%
Market median
+91% vs market
20212025
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AS Founder | Founder | 2019 |
CM Management | Management | 2026 |
| Former (2) | ||
LC Management | Management | 2023 – 2026 |
EK Management | Management | 2026 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2026 | |
| Board of Directors | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 | |
| Company | 100% | 100% | 2023 | |
| Company | 100% | 100% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EVIDENSIA DYREHOSPITAL A/S
Fasanvejens Dyreklinik ApS Board members of Fasanvejens Dyreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laura Christine Jarløv Kjøller | Management | 0 companies |
| Anne Sørensen | Founder | 0 companies |
| Evelina Karin Ögren | Management | 0 companies |
| Carl-Magnus Månsson | Management | 0 companies |
| Eric Mattias Lundström | Chairman | 0 companies |
| Rune Gottschalck Rehlund | Board of Directors | 0 companies |